Gardasil® as adjunctive therapy for respiratory papillomatosis at Red Cross Children’s Hospital, Cape Town
Background: Juvenile onset recurrent respiratory papillomatosis (JoRRP) is an incurable condition caused by human papilloma virus (HPV) types 6 and 11, often requiring repeated surgeries and in severe cases, tracheostomy. This imposes a significant socioeconomic burden on patients and families. Gard...
Saved in:
| Main Authors: | Shavina Frank, Jessica K. McGuire, Fiona Kabagenyi, Vincent Pretorius, Shazia Peer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2024-05-01
|
| Series: | Journal of the Colleges of Medicine of South Africa |
| Subjects: | |
| Online Access: | https://jcmsa.org.za/index.php/jcmsa/article/view/33 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Impact of Gardasil<sup>®</sup> in Recurrent Respiratory Papillomatosis: A Retrospective Study on RRP Patients
by: Jennifer Sieg, et al.
Published: (2025-02-01) -
HPV Vaccine: Current Data, Efficacy, and Clinical Implications
by: agnieszka marut, et al.
Published: (2025-05-01) -
Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015–2024
by: Qiong Liu, et al.
Published: (2025-12-01) -
HPV Vaccination Knowledge and Decision‐Making Among Adults 27 to 45 Years: A Large Online Survey
by: Matthew E. Lin, et al.
Published: (2025-06-01) -
Infección genital masculina por virus de papiloma humano
by: Alejandro Silva Garretón, et al.
Published: (2025-03-01)